Franklin Labs caused a kerfuffle in Oct. 2017 when it quietly put its Reading grow permit up for sale — including property and other assets — with a price tag of $20 million. A senior executive explained at the time that the company wanted to pursue an even more lucrative research license that would allow it to produce marijuana in conjunction with a Pennsylvania university — and sell cannabis at five dispensaries.